The Prostate Cancer Foundation (PCF) announces Adam Feldman, MD, Massachusetts General Hospital Cancer Center, has been awarded the Young Investigator Award for 2008

The Prostate Cancer Foundation (PCF) announced Adam Feldman, MD, Massachusetts General Hospital Cancer Center, has been awarded the PCF Young Investigator Award for 2008. The PCF Awards are given to 19 of the most innovative researchers to encourage them to continue their careers in prostate cancer research. The award provides recipients with $75,000 annually for three years to support specified research programs. The basis of his award was based on the premise that novel biomarkers for improved detection and prognosis of prostate cancer are needed. Intracellular, membrane-associated and secreted proteins are differentially expressed by prostate cancer cells as compared to benign prostate cells. Dr. Feldman proposes to discover these differentially expressed proteins in urine, a non-invasive practical biological fluid for biomarker discovery. The second goal of this project is to correlate biomarker findings with prostate cancer diagnosis, grade and pathologic stage.

Matthew Smith, MD, PhD, of the MGH Cancer Center, is a world leader in prostate cancer clinical investigations for bone stability and improved survivorship in patients on hormonal therapy, and Bruce Zetter, PhD, a world-leading cancer biologist at Harvard Medical School, will serve as Dr. Feldman’s co-mentors.